Encompass Health Corporation

EHC · NYSE · Stock · Healthcare
$126.30
+1.58% today
Delayed price,

What Encompass Health does

Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. It offers services through the Medicare program to the federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.

Key facts

Sector
Healthcare
Industry
Medical Care Facilities
Market cap
$12.46B
P/E (ttm)
21.1
Forward P/E
18.9
Dividend yield
0.68%
Beta
0.60
Profit margin
10.0%
Employees
29,699
Headquarters
Birmingham, AL, United States
Exchange
NYSE

Performance

1 Month
+3.7%
3 Months
+12.6%
6 Months
+18.7%
1 Year
+1.4%
5 Years
+175.5%
$92.7752-week range$127.99
Biggest setback — last 12 months
-25.1%
20 Oct 2025 → 26 Jan 2026
Fell from $126.13 to $94.53 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+33.6%
26 Jan 2026 → 14 Oct 2026
Ran from $94.53 to $126.30 — its strongest sustained advance this year.

Price outlook — trend & volatility model

▲ Trend: Uptrend
Price is above its 20-, 50- and 200-day averages, each stacked above the next — a classic technical uptrend structure.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$116.25 (-8.0%)$126.30$137.22 (+8.6%)
3 Months$109.41 (-13.4%)$126.30$145.80 (+15.4%)
6 Months$103.09 (-18.4%)$126.30$154.73 (+22.5%)
12 Months$94.78 (-25.0%)$126.30$168.31 (+33.3%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 28.7%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent headlines

Recent insider activity

Acquired 340 shares at $112.40 — Reidy Christopher R, Director · 2026-07-16
Acquired 259 shares at $112.43 — Christie Edward M III, Director · 2026-07-16
Acquired 29 shares — Williams Terrance, Director · 2026-07-16
Source: SEC Form 4 filings. An "acquired" entry with no price is typically a stock award or option exercise rather than an open-market purchase. Search all insider trades →

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.